Effects of Exercise in Patients With Coronary Artery Disease Aged 80 Years or Older

April 10, 2022 updated by: Maria Bäck, Sahlgrenska University Hospital, Sweden

Effects of Exercise in Patients With Coronary Artery Disease Aged 80 Years or Older - a Randomized Controlled Trial

The purpose of this study is to investigate the effects of exercise for patients with coronary artery disease (CAD) aged 80 years and older, with special reference to maximum aerobic capacity, muscle endurance, physical functioning, level of physical activity, health related quality of life, anxiety, depression and endothelial function, compared to a control group.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Select A State…
      • Gothenburg, Select A State…, Sweden, 41345
        • Department of physiotherapy, Sahlgrenska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

80 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of acute coronary artery disease
  • Aged 80 years or older

Exclusion Criteria:

  • Inability to understand or speak the Swedish language
  • Serious physical or psychological disease interfering with participation in an exercise intervention
  • Patients are already exercising three times or more/week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Individually prescribed hospital based exercise in group two times a week, home-based exercise once a week. The exercise intervention consists of interval based aerobic exercise on a bicycle ergometer 30 minutes with intensity level at 13-17 at Borg scale, resistance exercises and balance exercises
Individually prescribed hospital based exercise in group two times a week, home-based exercise once a week. The exercise intervention consists of interval based aerobic exercise on a bicycle ergometer 30 minutes with intensity level at 13-17 at Borg scale, resistance exercises and balance exercises
No Intervention: Control
Patients are asked to live as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in maximum aerobic capacity
Time Frame: At baseline and after 4 months
A maximum exercise test on an electronically braked cycle ergometer, with watts as marker of maximum aerobic capacity.
At baseline and after 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in level of physical activity
Time Frame: At baseline and after 4 months
Level of physical activity will be measured by an accelerometer and an activity diary
At baseline and after 4 months
Change in muscular endurance
Time Frame: At baseline and after 4 months
Will be measured by three clinical endurance tests including unilateral isotonic heel lift, unilateral isotonic shoulder flexion, bilateral isometric shoulder abduction
At baseline and after 4 months
Change in physical functioning
Time Frame: At baseline and after 4 months
Including tests of balance: short physical performance battery, one leg standing, timed up and go, and the activities specific balance confidence scale.
At baseline and after 4 months
Change in health related quality of life
Time Frame: At baselline and after 4 months
measured by a self-rated health questionnaire
At baselline and after 4 months
Change in anxiety and depression
Time Frame: At baseline and after 4 months
measured by the hospital anxiety and depression scale
At baseline and after 4 months
Change in endothelial function
Time Frame: At baseline and after 4 months
Evaluated with non-invasive ultrasound
At baseline and after 4 months
Change in transthoracic evaluation of resting coronary flow velocity
Time Frame: At baseline and after 4 months
At baseline and after 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Bäck, PhD, Department of Physiotherapy, Sahlgrenska University Hospital, Gothenburg, Sweden
  • Study Chair: Per Albertsson, PhD, Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (Actual)

May 1, 2019

Study Completion (Actual)

April 1, 2022

Study Registration Dates

First Submitted

October 21, 2013

First Submitted That Met QC Criteria

December 27, 2013

First Posted (Estimate)

January 1, 2014

Study Record Updates

Last Update Posted (Actual)

April 15, 2022

Last Update Submitted That Met QC Criteria

April 10, 2022

Last Verified

April 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe